免疫チェックポイント阻害薬と心臓有害事象
- 1 January 2019
- journal article
- Published by Japanese Circulation Society in Journal of JCS Cardiologists
- Vol. 28, 3-9
- https://doi.org/10.1253/jjcsc.28.0_3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysisBMC Medicine, 2015
- Confusing signals: Recent progress in CTLA-4 biologyTrends in Immunology, 2015
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2013
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapyJournal of Leukocyte Biology, 2013
- Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humansJCI Insight, 2011
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturationMedical Oncology, 2010
- Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanomaCancer, 2010
- Mechanisms maintaining peripheral toleranceNature Immunology, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetProceedings of the National Academy of Sciences of the United States of America, 2004